Fluorescent Lymphography-Guided Lymphadenectomy In Laparoscopic Proctectomy
NCT03854890 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2019-05-14
Summary
The purpose of this study is to compare the number of lymph nodes retrieved with or without the use of intraoperative fluorescence lymphography in laparoscopic radical resection of rectal cancer.
Conditions
Interventions
- DRUG
-
Indocyanine Green
Indocyanine Green will be injected to the submucosal layer around the lesion one day before surgery.
Sponsors & Collaborators
-
Fudan University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-01
- Primary Completion
- 2020-04-01
- Completion
- 2020-05-01
Countries
- China
Study Locations
More Related Trials
-
Sentinel Lymph Node Mapping in Rectal Cancer
NCT02869152 ·Status: UNKNOWN ·Phase: NA
-
Feasibility Study to Develop Sentinel Lymph Node Mapping in Rectal Cancer Patients
NCT02112240 ·Status: WITHDRAWN ·Phase: NA
-
A Trial of Robotic-assisted Versus Laparoscopic Abdominoperineal Resection for Treating Low Rectal Cancer
NCT01985698 ·Status: COMPLETED ·Phase: NA
-
Preservation Vs. Dissection of No. 253 Lymph Nodes of Robotic Resection for Mid/Low Rectal Cancer
NCT06956976 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC
NCT03725254 ·Status: UNKNOWN ·Phase: PHASE2
-
Lateral Lymph Node Dissection for Middle-low Rectal Cancer
NCT03826862 ·Status: UNKNOWN ·Phase: NA
-
Perfusion Outcomes With Near Infrared-Indocyanine Green Imaging System in Laparoscopic Total Mesorectal Excision for Mid- or Low-rectal CanceR
NCT04012645 ·Status: RECRUITING ·Phase: NA
-
PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery
NCT00004891 ·Status: COMPLETED ·Phase: NA
-
Total Mesorectum Excision With Left Colic Artery Preservation for the Treatment of Rectal Cancer
NCT03724591 ·Status: UNKNOWN ·Phase: NA
-
Carbon Nanoparticles vs Indocyanine Green
NCT04759820 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer
NCT02475889 ·Status: COMPLETED
-
Fluorescence Molecular Endoscopy and Molecular Fluorescence-guided Surgery in Locally Advanced Rectal Cancer
NCT04638036 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer
NCT05176964 ·Status: RECRUITING
-
Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis
NCT05057052 ·Status: RECRUITING ·Phase: PHASE2
-
Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis
NCT02979795 ·Status: UNKNOWN
-
Clinical Application of Carbon Nanoparticles in Lymph Node Tracing and Surgery Guiding of Colorectal Cancer
NCT06783985 ·Status: COMPLETED
-
Study of Pretargeted Radioimmunotherapy of a Anti-CEA Bispecific Antibody and Lu177-labeled Peptide in Colorectal Cancer
NCT00860860 ·Status: COMPLETED ·Phase: PHASE1
-
Intersphincteric Resection With or Without Intraoperative Radiation in Rectal Cancer
NCT03393234 ·Status: UNKNOWN ·Phase: NA
-
Extent of Lymph Node Dissection for Advanced Right-Sided Colon Cance
NCT06986538 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Efficacy Study of Cylindrical Abdominoperineal Resection to Treat Rectal Cancer
NCT00949273 ·Status: UNKNOWN
-
Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM
NCT05129774 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal Cancer
NCT02817126 ·Status: UNKNOWN ·Phase: NA
-
Magnetomotoric Ultrasound for Diagnostic Purposes in Rectal Cancer
NCT04622176 ·Status: RECRUITING
-
Optimal Surgery and MRI Based Radiochemotherapy in Rectal Carcinoma
NCT01325649 ·Status: COMPLETED
-
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases
NCT02419677 ·Status: COMPLETED ·Phase: PHASE2/PHASE3